Clinical Trials Logo

Clinical Trial Summary

A Phase 1 Study to Evaluate the Safety and Immunogenicity of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects


Clinical Trial Description

A Phase 1 Randomized, Single Center, Double-Blind, Placebo-Controlled, Dose-Response Study to Evaluate the Safety and Immunogenicity of rVSV-Nipah Virus Vaccine Candidate PHV02 in Healthy Adult Subjects ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05178901
Study type Interventional
Source Public Health Vaccines LLC
Contact
Status Recruiting
Phase Phase 1
Start date January 2022
Completion date January 2024

See also
  Status Clinical Trial Phase
Recruiting NCT04199169 - Safety and Immunogenicity of a Nipah Virus Vaccine Phase 1